Bristol-Myers Squibb have published this report, which is the result of an expert roundtable discussion on issues facing patients and healthcare professionals in trying to improve outcomes for oesophageal cancer patients.  Mimi-McCord, Chairman and Founder of Heartburn Cancer UK was part of the discussion group.